CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Sanofi SA is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Sanofi SA
46 Avenue de la Grande Armee
Phone: +33 153774000p:+33 153774000 PARIS, 75017  France Ticker: SANSAN

Business Summary
Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-YesYesYes-

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
3/31/202412/31/2023YesYes--Yes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Independent Chairman of the Board FredericOudea 60 5/25/2023 5/25/2023
Chief Executive Officer, Executive Director, Member of the Executive Committee PaulHudson 56 9/1/2019 9/1/2019
Chief Financial Officer, Member of the Executive Committee Francois-XavierRoger 62 4/1/2024 4/1/2024
12 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Sanofi SA FRANCE
Kiadis Pharma NV Paasheuvelweg 25A Amsterdam Netherlands
Kymab Limited The Bennet Building (B930) Cambridge United Kingdom
28 additional Subsidiary records available in full report.

Business Names
Business Name
0A2V
0O59
A. Nattermann & Cie. GmbH
132 additional Business Names available in full report.

General Information
Number of Employees: 87,994 (As of 12/31/2023)
Outstanding Shares: 1,251,349,581 (As of 12/31/2023)
Shareholders: 54,199
Stock Exchange: EPA
Fax Number: +33 153774463


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, April 27, 2024